Clinical Trial to Evaluate the Safety, Tolerability and Efficacy of CT303 in Patients With Psoriasis

Clinical trial NCT05258331 · UNKNOWN

Trial details

NCT number: NCT05258331
Sponsor: GC Cell Corporation
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Moderate to Severe Plaque Psoriasis

Start date: 2021-10-25
Primary completion: 2024-08-30
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.